Results 61 to 70 of about 58,392 (301)

Radionuclide Therapy of Bone Metastases [PDF]

Breast Care, 2012
The skeleton is a potential metastatic target of many malignant tumors. Up to 85% of prostate and breast cancer patients may develop bone metastases causing severe pain syndromes in many of them. In patients suffering from multilocular, mainly osteoblastic lesions and pain syndrome, radionuclide therapy is recommended for pain palliation.
Manfred, Fischer, Willm U, Kampen
openaire   +2 more sources

Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management

ChemBioChem, EarlyView.
Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh, Rupesh R. Kurhade, Abrar A. M. Siddiqui, Shaikh Shahbaz A. Majeed, Thomas J. Webster, Mohammad Intakhab Alam, Abdul Wasy Zia, Md. Faiyazuddin   +7 more
wiley   +1 more source

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy

Frontiers in Medicine, 2021
Samarium-153 (153Sm) is a highly interesting radionuclide within the field of targeted radionuclide therapy because of its favorable decay characteristics.
Michiel Van de Voorde, Charlotte Duchemin, Charlotte Duchemin, Reinhard Heinke, Reinhard Heinke, Laura Lambert, Eric Chevallay, Thomas Schneider, Miranda Van Stenis, Thomas Elias Cocolios, Thomas Cardinaels, Thomas Cardinaels, Bernard Ponsard, Maarten Ooms, Thierry Stora, Andrew R. Burgoyne   +15 more
doaj   +1 more source

Advances in targeted Alpha therapy for prostate cancer [PDF]

, 2019
BACKGROUND: Amongst therapeutic radiopharmaceuticals, targeted alpha therapy (TαT) can deliver potent and local radiation selectively to cancer cells as well as the tumor microenvironment and thereby control cancer while minimizing toxicity.
De Vincentis, G, Gerritsen, W, Gschwend, JE, Hacker, M, Lewington, V, O'Sullivan, JM, Oya, M, Pacilio, M, Parker, C, Sartor, O, Shore, N, Targeted Alpha Therapy Prostate Working Group   +11 more
core   +2 more sources

Nephrotoxicity after radionuclide therapies

Translational Oncology, 2022
Radioligand therapies have opened new treatment avenues for cancer patients. They offer precise tumor targeting with a favorable efficacy-to-toxicity profile. Specifically, the kidneys, once regarded as the critical organ for radiation toxicity, also show excellent tolerance to radiation doses as high as 50-60 Gy in selected cases.
Ashwin Singh Parihar, Sejal Chopra, Vikas Prasad   +2 more
openaire   +3 more sources

Contemporary and Emerging Therapies in the Management of Refractory Angina: A Clinical Review

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Refractory angina (RA) represents a growing challenge in clinical cardiology, particularly in patients with obstructive coronary artery disease (CAD) who remain symptomatic despite optimal medical therapy and who are not candidates for revascularization.
Alex Angers‐Goulet, Siddhartha Mengi, David Garcia Labbé, Can Manh Nguyen, Jean‐Michel Paradis   +4 more
wiley   +1 more source

Precautions for certain categories of individuals in contact with a patient after radionuclide therapy

Радиационная гигиена
Patients undergoing radionuclide therapy with radiopharmaceuticals may become a radiation source of external exposure. Release of the patients requires strict abidance of radiation safety regulations to minimize exposure to individuals in contact with ...
L. A. Chipiga, A. V. Likhacheva, I. A. Zvonova, A. V. Vodovatov, O. Yu. Toskin, A. A. Sapelnikov, K. S. Velichkina, A. S. Terenteva, A. A. Stanzhevsky   +8 more
doaj   +1 more source

POSSIBILITIES OF SYSTEMIC RADIONUCLIDE THERAPY IN PALLIATIVE TREATMENT OF P ATIENTS WITH METASTATIC BONES DISEASE

Исследования и практика в медицине, 2015
The pain syndrome accompanying metastatic damage of bones, significantly reduces quality of patients life. In recent decades, medical practice implemented methods systemic radionuclide therapy of bone metastases using different radionuclides, which ...
A. D. Kaprin, A. A. Kostin, A. V. Leontyev, T. N. Lazutina, I. V. Pylova, L. V. Dushakova   +5 more
doaj   +1 more source

Early Diagnosis of Alzheimer's disease by NIRF Spectroscopy and Nuclear Medicine [PDF]

, 2011
There is an urgent need for the early detection of diseases such as Alzheimer’s (AD) and Cancers in order to enable their successful treatment. Cancer is the second major cause of death after Heart Disease, and AD is the third major cause of death
I. C. Baianu
core   +1 more source

Activation cross-sections of longer lived products of deuteron induced nuclear reactions on ytterbium up to 40 MeV

, 2013
In the frame of a systematic study of the activation cross-sections of the deuteron induced nuclear reactions, excitation functions of the natYb(d,xn)177,173,172mg,171mg,170,169Lu, natYb(d,x)175,169Yb and natYb(d,x)173,172,168,167,165Tm reactions are ...
Baba, M., Ditrói, F., Hermanne, A., Ignatyuk, A. V., Mohammadi, A., Takács, S., Tárkányi, F., Yamazaki, H.   +7 more
core   +1 more source